Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +99.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Operating income changed +84.2% from the comparable as-filed period.
Free-cash-flow proxy changed +58.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating cash flow changed +61.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating margin changed +28373 basis points from the comparable as-filed period.
Net income changed +82.4% from the comparable as-filed period.
Gross margin changed +781 basis points from the comparable as-filed period.
Research & development changed -50.3% from the comparable as-filed period.
Shares outstanding changed -73.4% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes. This reverses 5 consecutive comparable moves in the opposite direction.
Working capital changed +613.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Stock-based compensation changed -84.4% from the comparable as-filed period.
Current ratio changed +54.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Working capital / assets changed +947 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cost of revenue changed -30.7% from the comparable as-filed period.
SBC / revenue changed -2086 basis points from the comparable as-filed period.
Current assets changed +15.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current liabilities changed -25.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capital expenditure changed +125.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Free-cash-flow margin changed +3020 basis points from the comparable as-filed period.
Operating cash-flow margin changed +3099 basis points from the comparable as-filed period.
R&D / revenue changed -3073 basis points from the comparable as-filed period.
Receivables / revenue changed -458 basis points from the comparable as-filed period.
Total assets changed -12.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Revenue changed -1.8% from the comparable as-filed period.
Gross profit changed +8.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capex / revenue changed +79 basis points from the comparable as-filed period.
Trade receivables changed -8.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.